Lista de obras - Kelly A. Newell - Dominio Público Uruguay

A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice

artículo científico publicado en 2013

A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia

artículo científico publicado en 2017

Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation

artículo científico publicado en 2015

Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia

artículo científico publicado en 2006

Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats

artículo científico publicado en 2015

Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies

artículo científico publicado en 2017

Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders

scientific article published on 19 July 2019

Chronic Adolescent CDPPB Treatment Alters Short-Term, but not Long-Term, Glutamatergic Receptor Expression

artículo científico publicado en 2018

Chronic treatment with simvastatin upregulates muscarinic M1/4 receptor binding in the rat brain.

artículo científico publicado en 2008

Could an allied health care approach reduce the unacceptable incidence of suicide after psychiatric hospital discharge?

artículo científico publicado en 2018

Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age.

artículo científico publicado en 2011

Dietary teasaponin ameliorates alteration of gut microbiota and cognitive decline in diet-induced obese mice

artículo científico publicado en 2017

Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia

artículo científico publicado en 2019

Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain

artículo científico publicado en 2008

Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia.

artículo científico publicado en 2017

Effects of short- and long-term aripiprazole treatment on Group I mGluRs in the nucleus accumbens: Comparison with haloperidol

artículo científico publicado en 2017

Erratum to: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.

artículo científico publicado en 2016

Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade

artículo científico publicado en 2009

Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice

artículo científico publicado en 2018

GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia

artículo científico publicado en 2014

High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain

artículo científico publicado en 2008

Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia

artículo científico publicado en 2006

Increased translocator protein (TSPO) binding throughout neurodevelopment in the perinatal phencyclidine rodent model of schizophrenia

scientific article published on 13 August 2019

Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients

artículo científico publicado en 2005

Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mTOR/4E-BP1 signaling pathway

artículo científico publicado en 2017

Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment

artículo científico publicado en 2013

Metabotropic glutamate receptor 5 in schizophrenia: emerging evidence for the development of antipsychotic drugs

artículo científico publicado en 2013

Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.

artículo científico

Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia

artículo científico publicado en 2015

Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics

artículo científico publicado en 2014

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.

artículo científico publicado en 2012

Molecular evidence of synaptic pathology in the CA1 region in schizophrenia.

artículo científico publicado en 2016

Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture.

artículo científico publicado en 2014

Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment

artículo científico publicado en 2016

Novel implications of Lingo-1 and its signaling partners in schizophrenia

artículo científico publicado en 2014

Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment

artículo científico publicado en 2007

Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors

artículo científico publicado en 2008

Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat m

artículo científico publicado en 2019

Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life

artículo científico publicado en 2011

Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function

artículo científico publicado en 2015

Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia

artículo científico publicado en 2008

Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia

artículo científico publicado en 2011

Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics.

artículo científico publicado en 2014

Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment.

artículo científico

Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment

artículo científico publicado en 2007

Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression

artículo científico publicado en 2008

Tacrine-Hydrogen Sulfide Donor Hybrid Ameliorates Cognitive Impairment in the Aluminum Chloride Mouse Model of Alzheimer's Disease

scientific article published on 20 June 2019

The effects of maternal antidepressant use on offspring behaviour and brain development: implications for risk of neurodevelopmental disorders

artículo científico publicado en 2017

mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia

artículo científico publicado en 2016

Lista de obras de Kelly A. Newell

A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice

A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia

Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation

Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia

Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats

Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies

Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders

Chronic Adolescent CDPPB Treatment Alters Short-Term, but not Long-Term, Glutamatergic Receptor Expression

Chronic treatment with simvastatin upregulates muscarinic M1/4 receptor binding in the rat brain.

Could an allied health care approach reduce the unacceptable incidence of suicide after psychiatric hospital discharge?

Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age.

Dietary teasaponin ameliorates alteration of gut microbiota and cognitive decline in diet-induced obese mice

Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia

Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain

Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia.

Effects of short- and long-term aripiprazole treatment on Group I mGluRs in the nucleus accumbens: Comparison with haloperidol

Erratum to: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.

Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade

Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice

GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia

High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain

Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia

Increased translocator protein (TSPO) binding throughout neurodevelopment in the perinatal phencyclidine rodent model of schizophrenia

Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients

Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mTOR/4E-BP1 signaling pathway

Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment

Metabotropic glutamate receptor 5 in schizophrenia: emerging evidence for the development of antipsychotic drugs

Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.

Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia

Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.

Molecular evidence of synaptic pathology in the CA1 region in schizophrenia.

Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture.

Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment

Novel implications of Lingo-1 and its signaling partners in schizophrenia

Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment

Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors

Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat m

Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life

Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function

Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia

Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia

Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics.

Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment.

Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment

Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression

Tacrine-Hydrogen Sulfide Donor Hybrid Ameliorates Cognitive Impairment in the Aluminum Chloride Mouse Model of Alzheimer's Disease

The effects of maternal antidepressant use on offspring behaviour and brain development: implications for risk of neurodevelopmental disorders

mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia